Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

about

Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

Item

http://www.wikidata.org/entity/Q58600801

description

scientific article published on 18 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Characterisation of circulatin ...... response: the COVERT-HF study

@en

Characterisation of circulatin ...... response: the COVERT-HF study

@nl

type

Item

label

Characterisation of circulatin ...... response: the COVERT-HF study

@en

Characterisation of circulatin ...... response: the COVERT-HF study

@nl

prefLabel

Characterisation of circulatin ...... response: the COVERT-HF study

@en

Characterisation of circulatin ...... response: the COVERT-HF study

@nl

P1476

Characterisation of circulatin ...... response: the COVERT-HF study

@en

P2093

Anntoniette Musa

http://www.w3.org/2001/XMLSchema#string

Christopher J McAloon

http://www.w3.org/2001/XMLSchema#string

Faizel Osman

http://www.w3.org/2001/XMLSchema#string

Harpal Randeva

http://www.w3.org/2001/XMLSchema#string

Jimiao Hu

http://www.w3.org/2001/XMLSchema#string

Julie Goodby

http://www.w3.org/2001/XMLSchema#string

Julie Jones

http://www.w3.org/2001/XMLSchema#string

Manuel Mayr

http://www.w3.org/2001/XMLSchema#string

Paul O'Hare

http://www.w3.org/2001/XMLSchema#string

Samantha Hyndman

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

MicroRNAs in cardiovascular disease: an introduction for clinicians

Membrane-associated matrix proteolysis and heart failure.

Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study.

Association of MicroRNAs and YRNAs With Platelet Function.

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.

Emerging biomarkers in heart failure.

P304

e000899

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/OPENHRT-2018-000899

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alan M Nevill

Prithwish Banerjee

P577

2018-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30364565

http://www.w3.org/2001/XMLSchema#string

P932

6196945

http://www.w3.org/2001/XMLSchema#string